Healthcare -
Biotechnology - NASDAQ - US
$ 0.53
-3.46 %
$ 2.51 M
Market Cap
-0.11
P/E
PCSA - GROSS PROFIT
Gross Profit PCSA - Processa Pharmaceuticals, Inc.
-222
LAST VALUE
99.57%
2 YEAR CAGR
79.61%
5 YEAR CAGR
-0.02%
10 YEAR CAGR